Ramipril and cardiovascular outcomes in patients on maintenance hemodialysis: The ARCADIA multicenter randomized controlled trial
Clinical Journal of the American Society of Nephrology | Apr 14, 2021
A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)
Journal of the American Society of Nephrology | Apr 01, 2021
Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD
Journal of Clinical Endocrinology and Metabolism | Mar 09, 2021
Most read this week